Company Information

CIN
Status
Date of Incorporation
18 October 2007
State / ROC
Bangalore / ROC Bangalore
Last Balance Sheet
31 March 2015
Last Annual Meeting
22 September 2015
Paid Up Capital
18,999,980
Authorised Capital
19,000,000

Directors

Suchi Agarwal
Suchi Agarwal
Director/Designated Partner
over 2 years ago
Vivek Kapoor
Vivek Kapoor
Director
about 10 years ago

Past Directors

Amit Agarwal
Amit Agarwal
Additional Director
over 10 years ago
Toshihiko Seki
Toshihiko Seki
Director
about 18 years ago
Hidenobu Sameshima
Hidenobu Sameshima
Director
about 18 years ago
Ken Takanashi
Ken Takanashi
Director
about 18 years ago
Koichiro Fukuzaki
Koichiro Fukuzaki
Director
about 18 years ago
Ryoichi Nagata
Ryoichi Nagata
Director
about 18 years ago

Patents

Primate Restraint Device

A primate restraint device capable of restricting the movement of a monkey and  particularly  capable of facilitating injection or blood collection. A primate restraint device comprising: a containing body having both side surfaces  a top surface  and a bottom surface; a door provided to the rear surface side of the...

Primate Restraint Device

A primate restraint device capable of restricting the movement of a monkey and  particularly  capable of facilitating transnasal intragastric administration or oral administration. A primate restraint device comprising: a containing body having both side surfaces  a top surface  and a bottom surface; a door provided...

Intranasal Delivery Devices

Devices for delivery of dry powder formulations are also provided. Devices can be single use devices. Formulations and methods of manufacture are provided for dry powder compositions suitable for intranasal administration. Also provided are methods of use for preventing or controlling emesis and other diseases and d...

Methods And Compositions For Intranasal Delivery

Provided herein are methods for generating dry vaccine powder formulations. Dry vaccine powder formulations can be used for intranasal delivery. Also provided are methods for stimulating local mucosal and systemic immunity by intranasal vaccine delivery.

Intranasal Delivery Devices

The present disclosure provides devices for delivery of powder formulations and methods of manufacture and use of such devices.

Conference Support System

[Problem] To enable a person intended by a chairperson to be effectively determined as a speaker by matching the hand-raising of the speaker and an indicating direction of the chairperson, and turning ON only a microphone of the matched speaker. [Solution] Provided is a conference support system including: a plurali...

Intranasal Pharmaceutical Powder Compositions

Disclosed herein are pharmaceutical powder compositions, methods of making such compositions, and uses thereof.

Methods And Compositions For Intranasal Delivery

Provided herein are methods for generating dry vaccine powder formulations. Dry vaccine powder formulations can be used for intranasal delivery. Also provided are methods for stimulating local mucosal. and systemic immunity by intranasal vaccine . delivery.

Powder Preparation For Transnasal Administration And Method For Producing Same

The present invention addresses the problem of providing a powder preparation for transnasal administration, the preparation efficiently demonstrating drug efficacy. The problem can be solved by a powder preparation for transnasal administration, containing composite particles in which an effective component and a w...

Administration Device

Provided is an administration device having a novel structure that enables anyone to uniformly jet and stably administer a substance to be administered such as a powdery drug. This device is a single-use type administration device 10 for administering a preset amount of a substance to be administered, such as a powd...

Adjuvant Composition And Vaccine Composition

An adjuvant composition containing an adjuvant and a complex including microparticles of a biodegradable polymer and/or cyclodextrin, wherein the adjuvant is incorporated into the microparticles of the biodegradable polymer and/or is clathrated in the cyclodextrin.